190 related articles for article (PubMed ID: 20862258)
21. Multinucleated cells formed on calcified dentine from mouse bone marrow cells treated with 1 alpha,25-dihydroxyvitamin D3 have ruffled borders and resorb dentine.
Sasaki T; Takahashi N; Higashi S; Suda T
Anat Rec; 1989 Jul; 224(3):379-91. PubMed ID: 2782622
[TBL] [Abstract][Full Text] [Related]
22. Macrophage colony-stimulating factor increases bone resorption by osteoclasts disaggregated from human fetal long bones.
Edwards M; Sarma U; Flanagan AM
Bone; 1998 Apr; 22(4):325-9. PubMed ID: 9556131
[TBL] [Abstract][Full Text] [Related]
23. Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone.
Flanagan AM; Chambers TJ
Bone Miner; 1989 Apr; 6(1):33-43. PubMed ID: 2526673
[TBL] [Abstract][Full Text] [Related]
24. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
Perez-Amodio S; Beertsen W; Everts V
J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the classical NF-kappaB pathway prevents osteoclast bone-resorbing activity.
Soysa NS; Alles N; Shimokawa H; Jimi E; Aoki K; Ohya K
J Bone Miner Metab; 2009; 27(2):131-9. PubMed ID: 19172225
[TBL] [Abstract][Full Text] [Related]
26. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts.
Yaroslavskiy BB; Li Y; Ferguson DJ; Kalla SE; Oakley JI; Blair HC
J Cell Biochem; 2004 Apr; 91(5):962-72. PubMed ID: 15034931
[TBL] [Abstract][Full Text] [Related]
27. Development of a new method for obtaining osteoclasts from endosteal surfaces.
May LG; Gay CV
In Vitro Cell Dev Biol Anim; 1996 May; 32(5):269-78. PubMed ID: 8792156
[TBL] [Abstract][Full Text] [Related]
28. The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.
Rajapurohitam V; Chalhoub N; Benachenhou N; Neff L; Baron R; Vacher J
Bone; 2001 May; 28(5):513-23. PubMed ID: 11344051
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of avian osteoclast bone resorption by monoclonal antibody 121F: a mechanism involving the osteoclast free radical system.
Collin-Osdoby P; Li L; Rothe L; Anderson F; Kirsch D; Oursler MJ; Osdoby P
J Bone Miner Res; 1998 Jan; 13(1):67-78. PubMed ID: 9443792
[TBL] [Abstract][Full Text] [Related]
30. Three-dimensional distribution of the clear zone of migrating osteoclasts on dentin slices in vitro.
Domon T; Yamazaki Y; Fukui A; Ohnishi Y; Takahashi S; Yamamoto T; Wakita M
Tissue Cell; 2002 Oct; 34(5):326-36. PubMed ID: 12270259
[TBL] [Abstract][Full Text] [Related]
31. Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films.
Lees RL; Sabharwal VK; Heersche JN
Bone; 2001 Feb; 28(2):187-94. PubMed ID: 11182377
[TBL] [Abstract][Full Text] [Related]
32. Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone.
Nakamura I; Pilkington MF; Lakkakorpi PT; Lipfert L; Sims SM; Dixon SJ; Rodan GA; Duong LT
J Cell Sci; 1999 Nov; 112 ( Pt 22)():3985-93. PubMed ID: 10547359
[TBL] [Abstract][Full Text] [Related]
33. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
34. Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells.
Li Z; Li C; Zhou Y; Chen W; Luo G; Zhang Z; Wang H; Zhang Y; Xu D; Sheng P
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E355-66. PubMed ID: 26670486
[TBL] [Abstract][Full Text] [Related]
35. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.
Woo JT; Nakagawa H; Notoya M; Yonezawa T; Udagawa N; Lee IS; Ohnishi M; Hagiwara H; Nagai K
Biol Pharm Bull; 2004 Apr; 27(4):504-9. PubMed ID: 15056855
[TBL] [Abstract][Full Text] [Related]
36. Characterization of bone mineral-resembling biomaterials for optimizing human osteoclast differentiation and resorption.
Nakamura M; Hentunen T; Salonen J; Nagai A; Yamashita K
J Biomed Mater Res A; 2013 Nov; 101(11):3141-51. PubMed ID: 23554241
[TBL] [Abstract][Full Text] [Related]
37. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
[TBL] [Abstract][Full Text] [Related]
38. Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts.
Fuller K; Lawrence KM; Ross JL; Grabowska UB; Shiroo M; Samuelsson B; Chambers TJ
Bone; 2008 Jan; 42(1):200-11. PubMed ID: 17962093
[TBL] [Abstract][Full Text] [Related]
39. Spatial organization of microfilaments and vitronectin receptor, alpha v beta 3, in osteoclasts. A study using confocal laser scanning microscopy.
Lakkakorpi PT; Helfrich MH; Horton MA; Väänänen HK
J Cell Sci; 1993 Mar; 104 ( Pt 3)():663-70. PubMed ID: 7686168
[TBL] [Abstract][Full Text] [Related]
40. Polyphosphate-mediated inhibition of tartrate-resistant acid phosphatase and suppression of bone resorption of osteoclasts.
Harada K; Itoh H; Kawazoe Y; Miyazaki S; Doi K; Kubo T; Akagawa Y; Shiba T
PLoS One; 2013; 8(11):e78612. PubMed ID: 24223830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
